Pulse Biosciences, Inc. · Brief

Next report

3 days

Nov 4 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 8≥ implied

Oct 30 '24±20.2%▼−1.64%×0.08

Mar 28 '25±23.8%▲+6.00%×0.25

May 8 '25±21.8%▲+1.31%×0.06

Aug 12 '25±15.7%▲+11.19%×0.71

Q3 FY25±28.5%▼−3.32%×0.12

Feb 19 '26±19.0%▼−14.59%×0.77

Q1 FY26±21.7%▼−3.84%×0.18

Q2 FY26±11.7%▲+10.90%×0.93

quarterimplied−30%0+30%realized×

Q2 FY26±11.7%▲+10.90%×0.93

Q1 FY26±21.7%▼−3.84%×0.18

Feb '26±19.0%▼−14.59%×0.77

Q3 FY25±28.5%▼−3.32%×0.12

Aug '25±15.7%▲+11.19%×0.71

May '25±21.8%▲+1.31%×0.06

2 older reports

Mar '25±23.8%▲+6.00%×0.25

Oct '24±20.2%▼−1.64%×0.08

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 4 report · est.

Bull2 of 3

3tracked funds holding PLSEN-PORT · Aug 31 '26

105managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

4 of 21of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

0.02%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

PLSE report session

No linked exposure.

Oct 21impliedImplied move: ±14.7% into Nov 4 earnings (Oct 21 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.